恒瑞医药11月11日斥资915.26万元回购15万股A股

Core Viewpoint - Heng Rui Medicine (600276)(01276) announced a share buyback plan, intending to repurchase 150,000 A-shares at a cost of 9.1526 million yuan [1] Group 1 - The company plans to execute the buyback on November 11, 2025 [1] - The total amount allocated for the buyback is approximately 9.15 million yuan [1] - The number of shares to be repurchased is 150,000 [1]